BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19881551)

  • 1. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
    Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
    Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
    Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
    Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
    Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
    Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
    PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
    Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
    Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
    Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
    Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
    Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China.
    Huang L; Zhang KL; Li H; Chen XY; Kong QY; Sun Y; Gao X; Guan HW; Liu J
    Hum Pathol; 2006 Dec; 37(12):1557-67. PubMed ID: 16949912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
    Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
    Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
    Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
    Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer.
    Shinmura K; Goto M; Suzuki M; Tao H; Yamada H; Igarashi H; Matsuura S; Maeda M; Konno H; Matsuda T; Sugimura H
    J Pathol; 2011 Nov; 225(3):414-23. PubMed ID: 21826668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
    Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
    Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.